Journals / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 2

Epidemiology of organophosphate intoxication and predictors of intermediate syndrome

Pages
279–282
Publication Date
2014-05-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Initial serum cholinesterase and glucose levels measured in the emergency department may be a useful marker in predicting organophosphate-induced intermediate syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To evaluate the usefulness of plasma glucose and serum cholinesterase levels as predictors of organophosphate-induced intermediate syndrome.
📊
Key Findings & Data:Materials and methods: Seventy-one organophosphate poisoning patients who were admitted to our emergency department during a 4-year period were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: Initial serum cholinesterase and glucose levels measured in the emergency department may be a useful marker in predicting organophosphate-induced intermediate syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Intoxication · organophosphate · hyperglycemia

Abstract

To evaluate the usefulness of plasma glucose and serum cholinesterase levels as predictors of organophosphate-induced intermediate syndrome. Materials and methods: Seventy-one organophosphate poisoning patients who were admitted to our emergency department during a 4-year period were evaluated retrospectively. Four patients were excluded from the study due to a lack of medical records. Categorical variables were analyzed using the chi-square test and nonparametric variables were analyzed using the Mann-Whitney U test. Results: Thirty-five (52.2%) patients were male and 32(47.8%) were female. Patients had a mean age of 39.4 ± 15.9 years and 70.1% of the patients were married. Oral intake (68.7%) was the most common method of intoxication, and attempted suicide (67.2%) was the most common cause. The most common organophosphates were methamidophos (20.8%), dichlorvos (19.4%), parathion (7.5%), and methyl parathion (7.5%). Fifty-seven (85%) patients were treated in the emergency observation unit and 10 (15%) patients were admitted to the intensive care unit. Eleven (16%) patients developed intermediate syndrome and had significantly lower levels of serum cholinesterase (P < 0.01) and higher blood glucose levels (P = 0.037). Conclusion: Initial serum cholinesterase and glucose levels measured in the emergency department may be a useful marker in predicting organophosphate-induced intermediate syndrome.

Özet

To evaluate the usefulness of plasma glucose and serum cholinesterase levels as predictors of organophosphate-induced intermediate syndrome. Materials and methods: Seventy-one organophosphate poisoning patients who were admitted to our emergency department during a 4-year period were evaluated retrospectively. Four patients were excluded from the study due to a lack of medical records. Categorical variables were analyzed using the chi-square test and nonparametric variables were analyzed using the Mann-Whitney U test. Results: Thirty-five (52.2%) patients were male and 32(47.8%) were female. Patients had a mean age of 39.4 ± 15.9 years and 70.1% of the patients were married. Oral intake (68.7%) was the most common method of intoxication, and attempted suicide (67.2%) was the most common cause. The most common organophosphates were methamidophos (20.8%), dichlorvos (19.4%), parathion (7.5%), and methyl parathion (7.5%). Fifty-seven (85%) patients were treated in the emergency observation unit and 10 (15%) patients were admitted to the intensive care unit. Eleven (16%) patients developed intermediate syndrome and had significantly lower levels of serum cholinesterase (P < 0.01) and higher blood glucose levels (P = 0.037). Conclusion: Initial serum cholinesterase and glucose levels measured in the emergency department may be a useful marker in predicting organophosphate-induced intermediate syndrome.

🔖

Cite This Article

ÇOLAK, Ş., ERDOĞAN, M. Ö., BAYDIN, A., AFACAN, M. A., KATI, C., DURAN, L. (2014). Epidemiology of organophosphate intoxication and predictors of intermediate syndrome. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 2, 279–282. https://ajindex.com/articles/394066

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Sogorb MA, Vilanova E, Carrera V. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosphorus insecticide and nerve agent poisonings. Toxicol Lett 2004; 151: 219–33.
  2. Langley R, Sumner D. Pesticide mortality in the United States, 1979–1998. Vet Hum Toxicol 2002; 44: 101–5.
  3. Öztürk MA, Keleştimur F, Kurtoğlu S, Güven K, Arslan D. Anticholinesterase poisoning in Turkey--clinical, laboratory and radiologic evaluation of 269 cases. Hum Exp Toxicol 1990; 9: 273–9.
  4. Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000; 38: 47–50.
  5. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. New Engl J Med 1987; 316: 761–3. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999; 54: 1073–88.
  6. Karalliedde L, Senanayake N. Organophosphorus insecticide poisoning. Br J Anesth 1989; 63: 736–50.
  7. Nouira S, Abroug F, Elatrous S. Prognostic value of serum cholinesterase in organophosphate poisoning. Chest 1994; 106: 1811–14.
  8. Yang CC, Deng JF. Intermediate syndrome following organophosphate insecticide poisoning. Chin Med Assoc 2007; 70: 467–72.
  9. Abdollahi M, Karami-Mohajeri S. A comprehensive review on experimental and clinical findings in intermediate syndrome caused by organophosphate poisoning. Toxicol Appl Pharmacol 2012; 258: 309–14.
  10. Dippenaar R, Diedericks RJ. Paediatric organophosphate poisoning – a rural hospital experience. S Afr Med J 2000; 95: 678–81.
  11. Emerson GM, Gray NM, Jelinek GA, Mountain D, Mead HJ. Organophosphate poisoning in Perth, Western Australia, 1987–1996. J Emerg Med 1996; 17: 273–7.
  12. Levy-Khademi L, Tenenbaum AN, Wexler ID, Amitai Y. Unintentional organophosphate intoxication in children. Pediatr Emerg Care 2007; 23: 716–8.
  13. Yurumez Y, Yavuz Y, Saglam H, Durukan P, Ozkan S, Akdur O, Yücel M. Electrocardiographic findings of acute organophosphate poisoning. J Emerg Med 2009; 36: 39–42.
  14. Pajoumand A, Shadnia S, Rezaie A, Abdi M, Abdollahi M. Benefits of magnesium sulfate in the management of acute human poisoning by organophosphorus insecticides. Hum Exp Toxicol 2004; 23: 565–9.
  15. Stallones L, Beseler C. Pesticide poisoning and depressive symptoms among farm residents. Ann Epidemiol 2002; 12: 389–94.
  16. Yurumez Y, Durukan P, Yavuz Y, Ikizceli I, Avsarogullari L, Ozkan S, Akdur O, Ozdemir C. Acute organophosphate poisoning in university ho